Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Related products AOD-9604 Research peptide
The Basics at a Glance Generic name: Retatrutide (development code: LY3437943) Manufacturer: Eli Lilly and Company Drug class: Triple agonist (GLP-1/GIP/glucagon receptor agonist) Administration: Once-weekly subcutaneous injection Dosing range: 2mg to 12mg weekly (gradual titration over 12+ weeks) Half-life: Approximately 6 days (reaches steady state in 45 weeks) FDA status: Phase 3 clinical trials (TRIUMPH program) Expected approval: 20272028 How Retatrutide Differs from Other GLP-1 Medications To understand retatrutide, it helps to see where it fits in the evolution of GLP-1 class medications
Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists
Oxidative Stress and Regulated Cell Death in Parkinsons Disease
Supplementation of diets with alpha-Tocopherol reduces serum concentrations of gamma- and Delta-Tocopherol in humans
Weitere spannende Rezepte, Fitness-Tips und News aus dem Shop erhltst Du auch in unserem Newsletter .
US$ 27.94
US$ 27.08
US$ 25.49
US$ 21.55
US$ 24.84
